ClinicalTrials.Veeva

Menu

Optimizing Preoperative Disinfection of Eyes

N

Norwegian University of Science and Technology

Status and phase

Terminated
Phase 4

Conditions

Eye Infections

Treatments

Drug: Povidone-Iodine 5%
Drug: Povidone-Iodine 0.3%

Study type

Interventional

Funder types

Other

Identifiers

NCT04745663
SW2019-3
2019-001179-35 (EudraCT Number)

Details and patient eligibility

About

Topical povidone-iodine (PI) is widely used as ocular antiseptic before and after surgery. The standard dose of 5% PI is however, associated with ocular irritation. We therefore want to test if a lower concentration of PI can be similarly efficacious in reducing bacterial growth while reducing ocular irritation.

Enrollment

150 patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients remitted to intravitreal injections at St. Olavs hospital.
  • Patients competent to give written consent

Exclusion criteria

  • Infectious disease
  • Known epitheliopathy
  • Contact lens wear
  • Use of prescription ophthalmic medications
  • Diabetes

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

150 participants in 2 patient groups

Povidone-Iodine 0.3 %
Experimental group
Description:
A tampon is soaked in diluted PI 0.3% and placed on the inside of the lower eyelid of one eye, where it will release iodine molecules for 20 minutes before being removed.
Treatment:
Drug: Povidone-Iodine 0.3%
Povidone-Iodine 5 %
Active Comparator group
Description:
Eye drops of 5% PI is the standard disinfection before eye surgery. The drops will be dripped in one eye and allowed to work for 2 minutes.
Treatment:
Drug: Povidone-Iodine 5%

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems